Hirotsugu Kenmotsu (Yusuke Tanigawara)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 40

Top Topics

Interstitial Lung Disease

Epidermal Growth Factor Receptor

Circulating Tumor

Top Venues

Cancer research communications

Cancer medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Hidenori Kage, Nana Akiyama, Hyangri Chang, Aya Shinozaki-Ushiku, Mirei Ka, Junichi Kawata, Manabu Muto, Yusuke Okuma, Natsuko Okita, Katsuya Tsuchihara, Junko Kikuchi, Hidekazu Shirota, Hideyuki Hayashi, Toshio Kokuryo, Hirotsugu Shiroma, Akira Hiraswa, Makoto Kubo, Hirotsugu Kenmotsu, Masahiko Tanabe, Tetsuo Ushiku, Kaori Muto, Yasuyuki Seto, Katsutoshi Oda
Patient survey on cancer genomic medicine in Japan under the national health insurance system. Cancer science 115 (3) (2024)
Hidenori Kage, Nana Akiyama, Hyangri Chang, Aya Shinozaki-Ushiku, Mirei Ka, Junichi Kawata, Manabu Muto, Yusuke Okuma, Natsuko Okita, Katsuya Tsuchihara, Junko Kikuchi, Hidekazu Shirota, Hideyuki Hayashi, Toshio Kokuryo, Hirotsugu Shiroma, Akira Hiraswa, Makoto Kubo, Hirotsugu Kenmotsu, Masahiko Tanabe, Tetsuo Ushiku, Kaori Muto, Yasuyuki Seto, Katsutoshi Oda
Patient survey on cancer genomic medicine in Japan under the national health insurance system. Cancer science 115 (3) (2024)
Hidenori Kage, Nana Akiyama, Hyangri Chang, Aya Shinozaki-Ushiku, Mirei Ka, Junichi Kawata, Manabu Muto, Yusuke Okuma, Natsuko Okita, Katsuya Tsuchihara, Junko Kikuchi, Hidekazu Shirota, Hideyuki Hayashi, Toshio Kokuryo, Hirotsugu Shiroma, Akira Hiraswa, Makoto Kubo, Hirotsugu Kenmotsu, Masahiko Tanabe, Tetsuo Ushiku, Kaori Muto, Yasuyuki Seto, Katsutoshi Oda
Patient survey on cancer genomic medicine in Japan under the national health insurance system. Cancer science (2024)
Hidenori Kage, Nana Akiyama, Hyangri Chang, Aya Shinozaki-Ushiku, Mirei Ka, Junichi Kawata, Manabu Muto, Yusuke Okuma, Natsuko Okita, Katsuya Tsuchihara, Junko Kikuchi, Hidekazu Shirota, Hideyuki Hayashi, Toshio Kokuryo, Hirotsugu Shiroma, Akira Hiraswa, Makoto Kubo, Hirotsugu Kenmotsu, Masahiko Tanabe, Tetsuo Ushiku, Kaori Muto, Yasuyuki Seto, Katsutoshi Oda
Patient survey on cancer genomic medicine in Japan under the national health insurance system. Cancer science 115 (3) (2024)
Hidenori Kage, Nana Akiyama, Hyangri Chang, Aya Shinozaki-Ushiku, Mirei Ka, Junichi Kawata, Manabu Muto, Yusuke Okuma, Natsuko Okita, Katsuya Tsuchihara, Junko Kikuchi, Hidekazu Shirota, Hideyuki Hayashi, Toshio Kokuryo, Hirotsugu Shiroma, Akira Hiraswa, Makoto Kubo, Hirotsugu Kenmotsu, Masahiko Tanabe, Tetsuo Ushiku, Kaori Muto, Yasuyuki Seto, Katsutoshi Oda
Patient survey on cancer genomic medicine in Japan under the national health insurance system. Cancer science 115 (3) (2024)
Takehiro Umemura, Hirotsugu Kenmotsu, Daisuke Hazama, Shunsuke Teraoka, Hiroshi Kobe, Kazuhiko Nakagawa, Teppei Yamaguchi, Takeshi Masuda, Toshihide Yokoyama, Isamu Okamoto, Koji Haratani, Daisuke Hayakawa, Masahide Oki, Shinnosuke Takemoto, Tomohiro Ozaki, Yusaku Akashi, Akito Hata, Hiroya Hashimoto, Nobuyuki Yamamoto, Kazuhiko Nakagawa
Liquid biopsy detects genomic drivers in NSCLC without EGFR mutations by single-plex testing: WJOG13620L. Cancer medicine (2023)
Hidenori Kage, Katsutoshi Oda, Manabu Muto, Katsuya Tsuchihara, Natsuko Okita, Yusuke Okuma, Junko Kikuchi, Hidekazu Shirota, Hideyuki Hayashi, Toshio Kokuryo, Daisuke Sakai, Akira Hiraswa, Makoto Kubo, Hirotsugu Kenmotsu, Nana Akiyama, Aya Shinozaki-Ushiku, Masahiko Tanabe, Tetsuo Ushiku, Kiyoshi Miyagawa, Yasuyuki Seto
Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan. Cancer science (2023)
Keiichi Ohshima, Takeshi Nagashima, Keiichi Fujiya, Keiichi Hatakeyama, Yuko Watanabe, Kimiko Morimoto, Fukumi Kamada, Yuji Shimoda, Sumiko Ohnami, Akane Naruoka, Masakuni Serizawa, Shumpei Ohnami, Hirotsugu Kenmotsu, Akio Shiomi, Yasuhiro Tsubosa, Etsuro Bando, Teiichi Sugiura, Takashi Sugino, Masanori Terashima, Katsuhiko Uesaka, Kenichi Urakami, Yasuto Akiyama, Ken Yamaguchi
Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557-558 Deletion Mutations. Cancer research communications 3 (4) (2023)
Keiichi Ohshima, Takeshi Nagashima, Keiichi Fujiya, Keiichi Hatakeyama, Yuko Watanabe, Kimiko Morimoto, Fukumi Kamada, Yuji Shimoda, Sumiko Ohnami, Akane Naruoka, Masakuni Serizawa, Shumpei Ohnami, Hirotsugu Kenmotsu, Akio Shiomi, Yasuhiro Tsubosa, Etsuro Bando, Teiichi Sugiura, Takashi Sugino, Masanori Terashima, Katsuhiko Uesaka, Kenichi Urakami, Yasuto Akiyama, Ken Yamaguchi
Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557-558 Deletion Mutations. Cancer research communications 3 (4) (2023)
Keiichi Ohshima, Takeshi Nagashima, Keiichi Fujiya, Keiichi Hatakeyama, Yuko Watanabe, Kimiko Morimoto, Fukumi Kamada, Yuji Shimoda, Sumiko Ohnami, Akane Naruoka, Masakuni Serizawa, Shumpei Ohnami, Hirotsugu Kenmotsu, Akio Shiomi, Yasuhiro Tsubosa, Etsuro Bando, Teiichi Sugiura, Takashi Sugino, Masanori Terashima, Katsuhiko Uesaka, Kenichi Urakami, Yasuto Akiyama, Ken Yamaguchi
Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557-558 Deletion Mutations. Cancer research communications 3 (4) (2023)
Hirotsugu Kenmotsu, Nobuyuki Yamamoto, Toshihiro Misumi, Kiyotaka Yoh, Haruhiro Saito, Shunichi Sugawara, Koji Yamazaki, Kazuhiko Nakagawa, Kenji Sugio, Takashi Seto, Shinichi Toyooka, Hiroshi Date, Tetsuya Mitsudomi, Yasuto Yoneshima, Kohei Yokoi, Hideo Saka, Hiroaki Okamoto, Yuichi Takiguchi, Toshiaki Takahashi, Masahiro Tsuboi
Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Keiichi Ohshima, Takeshi Nagashima, Keiichi Fujiya, Keiichi Hatakeyama, Yuko Watanabe, Kimiko Morimoto, Fukumi Kamada, Yuji Shimoda, Sumiko Ohnami, Akane Naruoka, Masakuni Serizawa, Shumpei Ohnami, Hirotsugu Kenmotsu, Akio Shiomi, Yasuhiro Tsubosa, Etsuro Bando, Teiichi Sugiura, Takashi Sugino, Masanori Terashima, Katsuhiko Uesaka, Kenichi Urakami, Yasuto Akiyama, Ken Yamaguchi
Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557-558 Deletion Mutations. Cancer research communications 3 (4) (2023)
Keiichi Ohshima, Takeshi Nagashima, Keiichi Fujiya, Keiichi Hatakeyama, Yuko Watanabe, Kimiko Morimoto, Fukumi Kamada, Yuji Shimoda, Sumiko Ohnami, Akane Naruoka, Masakuni Serizawa, Shumpei Ohnami, Hirotsugu Kenmotsu, Akio Shiomi, Yasuhiro Tsubosa, Etsuro Bando, Teiichi Sugiura, Takashi Sugino, Masanori Terashima, Katsuhiko Uesaka, Kenichi Urakami, Yasuto Akiyama, Ken Yamaguchi
Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557-558 Deletion Mutations. Cancer research communications 3 (4) (2023)
Keiichi Ohshima, Takeshi Nagashima, Keiichi Fujiya, Keiichi Hatakeyama, Yuko Watanabe, Kimiko Morimoto, Fukumi Kamada, Yuji Shimoda, Sumiko Ohnami, Akane Naruoka, Masakuni Serizawa, Shumpei Ohnami, Hirotsugu Kenmotsu, Akio Shiomi, Yasuhiro Tsubosa, Etsuro Bando, Teiichi Sugiura, Takashi Sugino, Masanori Terashima, Katsuhiko Uesaka, Kenichi Urakami, Yasuto Akiyama, Ken Yamaguchi
Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557-558 Deletion Mutations. Cancer research communications 3 (4) (2023)
Kohei Otsubo, Junji Kishimoto, Masahiko Ando, Hirotsugu Kenmotsu, Yuji Minegishi, Hidehito Horinouchi, Terufumi Kato, Eiki Ichihara, Masashi Kondo, Shinji Atagi, Motohiro Tamiya, Satoshi Ikeda, Toshiyuki Harada, Shinnosuke Takemoto, Hidetoshi Hayashi, Keita Nakatomi, Yuichiro Kimura, Yasuhiro Kondoh, Masahiko Kusumoto, Kazuya Ichikado, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Yoichi Nakanishi, Isamu Okamoto
Nintedanib plus chemotherapy for non-small cell lung cancer with IPF: a randomized phase 3 trial. The European respiratory journal (2022)
Hirotsugu Kenmotsu, Shunichi Sugawara, Yasutaka Watanabe, Haruhiro Saito, Morihito Okada, Toyofumi Fengshi Chen-Yoshikawa, Yuichiro Ohe, Wataru Nishio, Shizuka Nakagawa, Haruka Nagao
Adjuvant atezolizumab in Japanese patients with resected stage IB-IIIA non-small cell lung cancer (IMpower010). Cancer science (2022)
Shoko Noda-Narita, Tomoyuki Naito, Hibiki Udagawa, Koichi Goto, Taichi Miyawaki, Nobuaki Mamesaya, Kazuhisa Nakashima, Hirotsugu Kenmotsu, Tadasuke Shimokawaji, Terufumi Kato, Taiki Hakozaki, Yusuke Okuma, Masaki Nakamura, Yuko Nakayama, Hirokazu Watanabe, Masahiko Kusumoto, Yuichiro Ohe, Hidehito Horinouchi
Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy. Cancer science (2022)
Taichi Miyawaki, Hirotsugu Kenmotsu, Kosei Doshita, Hiroaki Kodama, Naoya Nishioka, Yuko Iida, Eriko Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Ryo Ko, Kazushige Wakuda, Akira Ono, Tateaki Naito, Haruyasu Murakami, Keita Mori, Hideyuki Harada, Masahiro Endo, Kazuhisa Takahashi, Toshiaki Takahashi
Clinical impact of tumour burden on the efficacy of PD-1/PD-L1 inhibitors plus chemotherapy in non-small-cell lung cancer. Cancer medicine (2022)
Mitsuho Imai, Yoshiaki Nakamura, Kuniko Sunami, Hidenori Kage, Keigo Komine, Takafumi Koyama, Toraji Amano, Daisuke Ennishi, Masashi Kanai, Hirotsugu Kenmotsu, Takahiro Maeda, Sachi Morita, Daisuke Sakai, Hideaki Bando, Akitaka Makiyama, Tatsuya Suzuki, Makoto Hirata, Shinji Kohsaka, Katsuya Tsuchihara, Yoichi Naito, Takayuki Yoshino
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors. Cancer science 113 (11) (2022)
Kuniko Sunami, Yoichi Naito, Keigo Komine, Toraji Amano, Daisuke Ennishi, Mitsuho Imai, Hidenori Kage, Masashi Kanai, Hirotsugu Kenmotsu, Takafumi Koyama, Takahiro Maeda, Sachi Morita, Daisuke Sakai, Shinji Kohsaka, Katsuya Tsuchihara, Yusuke Saigusa, Takayuki Yoshino
Chronological improvement in precision oncology implementation in Japan. Cancer science 113 (11) (2022)
Akihiro Yoshimura, Tadaaki Yamada, Masakuni Serizawa, Hisanori Uehara, Keiko Tanimura, Yusuke Okuma, Akito Fukuda, Satoshi Watanabe, Naoya Nishioka, Takayuki Takeda, Yusuke Chihara, Shinnosuke Takemoto, Taishi Harada, Osamu Hiranuma, Yukina Shirai, Takehito Shukuya, Akihiro Nishiyama, Yasuhiro Goto, Shinsuke Shiotsu, Kei Kunimasa, Kenji Morimoto, Yuki Katayama, Kenichi Suda, Tetsuya Mitsudomi, Seiji Yano, Hirotsugu Kenmotsu, Toshiaki Takahashi, Koichi Takayama
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib. Cancer science (2022)
Masafumi Sata, Shinichi Sasaki, Katsunori Oikado, Yoshinobu Saito, Junya Tominaga, Fumikazu Sakai, Terufumi Kato, Tae Iwasawa, Hirotsugu Kenmotsu, Masahiko Kusumoto, Tomohisa Baba, Masahiro Endo, Yutaka Fujiwara, Hiroaki Sugiura, Noriyo Yanagawa, Yoshihiko Ito, Takahiko Sakamoto, Yuichiro Ohe, Kazuyoshi Kuwano
Treatment and relapse of interstitial lung disease in nivolumab-treated patients with non-small cell lung cancer. Cancer science 112 (4) (2021)
Toshiaki Takahashi, Kazuko Sakai, Hirotsugu Kenmotsu, Kiyotaka Yoh, Haruko Daga, Tatsuo Ohira, Tsuyoshi Ueno, Tadashi Aoki, Hidetoshi Hayashi, Koji Yamazaki, Yukio Hosomi, Toyofumi F Chen-Yoshikawa, Norihito Okumura, Yuichi Takiguchi, Akimasa Sekine, Tomohiro Haruki, Hiromasa Yamamoto, Yuki Sato, Hiroaki Akamatsu, Takashi Seto, Sho Saeki, Kenji Sugio, Makoto Nishio, Hidetoshi Inokawa, Nobuyuki Yamamoto, Kazuto Nishio, Masahiro Tsuboi
Predictive value of EGFR mutation in non-small-cell lung cancer patients treated with platinum doublet postoperative chemotherapy. Cancer science (2021)
Hirotsugu Kenmotsu, Seiji Niho, Masahiro Tsuboi, Masashi Wakabayashi, Junko Eba, Hisao Asamura, Yuichiro Ohe, Shun-Ichi Watanabe
Reply to J. L. Derks et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (13) (2021)
Taichi Miyawaki, Hirotsugu Kenmotsu, Michitoshi Yabe, Hiroaki Kodama, Naoya Nishioka, Eriko Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Kazushige Wakuda, Akira Ono, Shoichi Deguchi, Koichi Mitsuya, Tateaki Naito, Haruyasu Murakami, Keita Mori, Hideyuki Harada, Nakamasa Hayashi, Kazuhisa Takahashi, Toshiaki Takahashi
Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis. Investigational new drugs 39 (6) (2021)
Kosei Doshita, Hirotsugu Kenmotsu, Shota Omori, Yuya Tabuchi, Takanori Kawabata, Hiroaki Kodama, Naoya Nishioka, Eriko Miyawaki, Yuko Iida, Taichi Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, Ryo Ko, Kazushige Wakuda, Akira Ono, Tateaki Naito, Haruyasu Murakami, Keita Mori, Hideyuki Harada, Takeshi Kaneko, Toshiaki Takahashi
Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis. Investigational new drugs (2021)
Hirotsugu Kenmotsu, Akifumi Notsu, Keita Mori, Shota Omori, Takahiro Tsushima, Yasuomi Satake, Yoshihiro Miki, Masakazu Abe, Masahito Ogiku, Toshio Nakamura, Masakazu Takagi, Hideto Ochiai, Hirofumi Yasui, Toshiaki Takahashi
Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study. Cancer medicine 10 (3) (2021)
Hiroaki Kodama, Hirotsugu Kenmotsu, Takanori Kawabata, Akifumi Notsu, Michitoshi Yabe, Naoya Nishioka, Eriko Miyawaki, Taichi Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Kazushige Wakuda, Akira Ono, Tateaki Naito, Haruyasu Murakami, Toshiaki Takahashi
Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non-small cell lung cancer harboring EGFR mutation. Cancer medicine 10 (21) (2021)
Yoshinobu Saito, Shinichi Sasaki, Katsunori Oikado, Junya Tominaga, Masafumi Sata, Fumikazu Sakai, Terufumi Kato, Tae Iwasawa, Hirotsugu Kenmotsu, Masahiko Kusumoto, Tomohisa Baba, Masahiro Endo, Yutaka Fujiwara, Hiroaki Sugiura, Noriyo Yanagawa, Yoshihiko Ito, Takahiko Sakamoto, Yuichiro Ohe, Kazuyoshi Kuwano
Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non-small cell lung cancer. Cancer science 112 (4) (2021)
Yutaka Fujiwara, Hirotsugu Kenmotsu, Noboru Yamamoto, Toshio Shimizu, Kan Yonemori, Christopher Ocampo, Apurvasena Parikh, Sumiko Okubo, Kazuteru Fukasawa, Haruyasu Murakami
Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors. Cancer medicine 10 (7) (2021)
Satoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu, Akimasa Sekine, Tomohisa Baba, Takashi Ogura
Current Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia. Cancers 13 (16) (2021)
Taichi Miyawaki, Hirotsugu Kenmotsu, Hideyuki Harada, Yasuhisa Ohde, Yasutaka Chiba, Koji Haratani, Tamio Okimoto, Tomohiro Sakamoto, Kazushige Wakuda, Kentaro Ito, Takehiro Uemura, Shinya Sakata, Yoshihito Kogure, Yasumasa Nishimura, Kazuhiko Nakagawa, Nobuyuki Yamamoto
Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L). BMC cancer 21 (1) (2021)
Hirotsugu Kenmotsu, Seiji Niho, Masahiro Tsuboi, Masashi Wakabayashi, Genichiro Ishii, Kazuo Nakagawa, Haruko Daga, Hiroshi Tanaka, Haruhiro Saito, Keiju Aokage, Toshiaki Takahashi, Toshi Menju, Takashi Kasai, Ichiro Yoshino, Koichi Minato, Morihito Okada, Junko Eba, Hisao Asamura, Yuichiro Ohe, Shun-Ichi Watanabe
Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung: JCOG1205/1206. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (36) (2020)
Taichi Miyawaki, Kazushige Wakuda, Hirotsugu Kenmotsu, Eriko Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Akira Ono, Tateaki Naito, Haruyasu Murakami, Akifumi Notsu, Keita Mori, Hideyuki Harada, Masahiro Endo, Yasuhisa Ohde, Kazuhisa Takahashi, Toshiaki Takahashi
Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapy. Cancer science 112 (1) (2020)
Kazuko Sakai, Masahiro Tsuboi, Hirotsugu Kenmotsu, Takeharu Yamanaka, Toshiaki Takahashi, Koichi Goto, Haruko Daga, Tatsuo Ohira, Tsuyoshi Ueno, Tadashi Aoki, Kazuhiko Nakagawa, Koji Yamazaki, Yukio Hosomi, Koji Kawaguchi, Norihito Okumura, Yuichi Takiguchi, Akimasa Sekine, Tomohiro Haruki, Hiromasa Yamamoto, Yuki Sato, Hiroaki Akamatsu, Takashi Seto, Sho Saeki, Kenji Sugio, Makoto Nishio, Kazunori Okabe, Nobuyuki Yamamoto, Kazuto Nishio
Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR). Cancer science 112 (1) (2020)
Naoya Nishioka, Tateaki Naito, Akifumi Notsu, Keita Mori, Hiroaki Kodama, Eriko Miyawaki, Taichi Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Haruyasu Murakami, Koichi Takayama, Toshiaki Takahashi
Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non-small cell lung cancer. Cancer medicine 10 (1) (2020)
Hirotsugu Kenmotsu, Kiyotaka Yoh, Keita Mori, Akira Ono, Tomohisa Baba, Yutaka Fujiwara, Ou Yamaguchi, Ryo Ko, Hiroaki Okamoto, Nobuyuki Yamamoto, Takashi Ninomiya, Takashi Ogura, Terufumi Kato
Phase II study of nab-paclitaxel + carboplatin for patients with non-small-cell lung cancer and interstitial lung disease. Cancer science 110 (12) (2019)
Masaru Watanabe, Hirotsugu Kenmotsu, Ryo Ko, Kazushige Wakuda, Akira Ono, Hisao Imai, Tetsuhiko Taira, Tateaki Naito, Haruyasu Murakami, Masato Abe, Masahiro Endo, Takashi Nakajima, Yasuhiro Koh, Toshiaki Takahashi
Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter. Cancer science 109 (8) (2018)
Hirotsugu Kenmotsu, Chiyo K Imamura, Akira Ono, Shota Omori, Kazuhisa Nakashima, Kazushige Wakuda, Tetsuhiko Taira, Tateaki Naito, Haruyasu Murakami, Toshiaki Takahashi, Hirotsugu Kenmotsu
The effects of advanced age and serum α1 -acid glycoprotein on docetaxel unbound exposure and dose-limiting toxicity in cancer patients. British journal of clinical pharmacology 83 (11) (2017)
Nobuaki Mamesaya, Hirotsugu Kenmotsu, Toshiaki Takahashi
Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab. Investigational new drugs 35 (6) (2017)